Global CDx & Personalized Medicine Summit 2018

The Global CDx & Personalized Medicine Summit 2018 is dedicated to Analyze and tackle the latest and greatest opportunities in the CDx and personalized medicine industry.

Topics

• Novel Diagnostic Technologies
• Targeted Next Generation Sequencing Panels for the Development of CDx
• Partnering strategies to achieve successful commercialization of CDx
• Strategic Partnerships for CDx – Challenges and Opportunities
• Emerging approach to precision medicine strategy
• Implementation of a Personalized Medicine program
• Finding the appropriate business models for CDx companies
• Partnering to Deliver Personalized Medicine
• The laboratory developed test (LDT) & In vitro diagnostic (IVD) Models
• The role of complementary diagnostics in targeted therapy selection
• Use of pharmacogenomics analyses to guide diagnosis and treatment
• Liquid biopsy methodologies for non-invasive diagnostic development
• Regulatory Update on Companion Diagnostics
• Implementation of molecularly-based personalized medicine approaches into clinical practice
• Regulatory and Commercial Considerations
• Emerging investment trends and opportunities

Who should Attend

Senior attendees with responsibilities in:

• Biomarkers
• Companion Diagnostics
• Medical Sciences
• Regulatory Affairs
• Biomarker & Experimental Medicine
• Companion Diagnostic Development
• Personalized Healthcare
• Diagnostic & Experimental Pathology
• New Product Development
• Corporate Development & Ventures
• Pharmaceutical and Biotech Companies
• Biologics/Biotechnology/Biogenerics
• Healthcare Providers
• Quality Affairs/ Quality Control
• Investors & Financiers
• Government/Policy Makers
• Intellectual property
• Regulatory Compliance
• Business Development From Industries Including
• Preclinical and Clinical Development
• Biotechnology
• Pharmaceutical
• CDx entities
• Research Institutes
• Diagnostics
• Biopharmaceutical
• Healthcare Providers
• Solution provider companies
• Investors & Financiers